Image de couverture de livre

Utilisation Trends of Lisdexamfetamine: Insights From Recent Medicine Shortages in Australia

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jack Janetzki, Lisa Kalisch, Kelly Hall, Nicole Pratt
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Pharmacoepidemiology and Drug Safety
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community
par: Maarten Lambert, et autres
Publié: (2025)

Medicine utilization studies in Australian individual‐level dispensing data: A blinded, multi‐center replicated analysis
par: Malcolm B. Gillies, et autres
Publié: (2024)

Keep Your Guard Up: The Potential Impact of Drug Shortages on Pharmacoepidemiological Studies
par: Araniy Santhireswaran, et autres
Publié: (2024)

The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia
par: Helga Zoega, et autres
Publié: (2024)

Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages
par: Katie J. Suda, et autres
Publié: (2026)

Longitudinal Trends in Non‐Insulin Pharmacotherapy for Type 2 Diabetes in Australian Women of Reproductive Age: Implications for Planned and Unplanned Pregnancies
par: Farah Hashmani, et autres
Publié: (2026)

Trends in the Dispensing of Oral Anti‐Cancer Medications Across Australia Over 10 Years
par: Michael James Leach, et autres
Publié: (2025)

Treatment Persistence and Variations in Prescribing Oral, Injectable, and Inhaled Corticosteroids: A Population‐Based Drug Utilisation Study
par: Eleni Domzaridou, et autres
Publié: (2025)

Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations
par: Thomas Goedecke, et autres
Publié: (2024)

Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018
par: Todd Sponholtz, et autres
Publié: (2024)

Data Resource Profile: The Danish National Hospital Medicine Register
par: Michael Asger Andersen, et autres
Publié: (2024)

Impact of COVID ‐19 Restrictions on Nationwide Antipsychotic Use: Results From the Trends in Drug Utilization During COVID ‐19 Pandemic in Turkey ( PANDUTI ‐ TR ) Study
par: Caner Vizdiklar, et autres
Publié: (2026)

Perinatal Outcomes After the Use of Kampo Medicines Containing Ephedra During Pregnancy
par: Aoi Noda, et autres
Publié: (2025)

Temporal Trend in Selective Cyclooxygenase‐2 Inhibitors Sales in Brazilian Drugstores
par: Tayanny Margarida Menezes Almeida Biase, et autres
Publié: (2025)

Mental Health and Medicine Use for Headache: A Nationally Representative Study of Adolescents in Denmark
par: Bjørn Evald Holstein, et autres
Publié: (2024)

Trends in Medication Use Among Young Adults and the Covid‐19 Pandemic Effect
par: Meital Zur, et autres
Publié: (2025)

Post‐Market Evidence for Cancer Medicines in Regulatory and Clinical Decision‐Making: A Scoping Review
par: Eliza J. McEwin, et autres
Publié: (2025)

Increasing Prevalence of Long‐Term Antidepressant Use in Australia: A Retrospective Observational Study
par: R. A. D. L. M. K. Ranwala, et autres
Publié: (2025)

Prevalence Trends and Patterns of Perinatal ADHD Stimulant Medication Use in British Columbia, Canada
par: Amanda Nitschke, et autres
Publié: (2025)

Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal Management
par: G. Niklas Norén, et autres
Publié: (2025)

A Cross‐Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real‐World Evidence
par: Maria Melinder, et autres
Publié: (2026)

Epidemiological Profile of Exogenous Intoxications by Self‐Medication in Brazil: A Decade of Trends and the Impact of the COVID ‐19
par: Lucas Borges Pereira, et autres
Publié: (2025)

National Trends and Disparities in Herpes Zoster Vaccination Among US Older Adults With Diabetes, 2008–2023
par: Chun‐Tse Hung, et autres
Publié: (2025)

Use of privacy‐preserving record linkage to examine the dispensing of pharmaceutical benefits scheme medicines to pregnant women in Western Australia
par: Erin Kelty, et autres
Publié: (2024)

INSIGHT : A Tool for Fit‐for‐Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety
par: Vjola Hoxhaj, et autres
Publié: (2025)

The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study
par: Aoi Noda, et autres
Publié: (2024)

Trends and Patterns of Adverse Drug Reaction Reporting in Sierra Leone: A Retrospective Analysis of VigiFlow Data (2008–2022)
par: Isatu Jalloh, et autres
Publié: (2026)

Analysis of Longitudinal Patterns and Predictors of Medicine Use in Residential Aged Care Using Group‐Based Trajectory Modeling: The “MEDTRAC‐Cardiovascular” Longitudinal Cohort Study
par: Nasir Wabe, et autres
Publié: (2024)

Oral Anticoagulant Use Among Older Adults in Long‐Term Care Facilities: Trends Over Time and Impact of High‐Risk Comorbidities
par: S. L. Harrison, et autres
Publié: (2026)

Evaluating Data Quality by Proxy: Can We Evaluate All Dimensions of the European Medicines Agency Data Quality Framework for Registry‐Based Post‐Authorization Safety Studies?
par: Pamela Dobay, et autres
Publié: (2026)

Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action
par: Samantha Lane, et autres
Publié: (2024)

An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer
par: Jessica A. Perhanidis, et autres
Publié: (2024)

Medication, Vaccine, and Folic Acid Use Among Pregnant Women in Belgium: Insights from the BELpREG Cohort
par: Laure Sillis, et autres
Publié: (2026)

Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
par: W. N. Kelly, et autres
Publié: (2024)

Identifying COVID ‐19 Disease Severity in Real‐World Data: Implications for Medical Product Effectiveness Studies
par: Mayura U. Shinde, et autres
Publié: (2026)

Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries
par: Yun Lu, et autres
Publié: (2025)

Validation of ICD‐10 Diagnosis Codes for Identification of Acute Myocardial Infarction From a US Integrated Healthcare System
par: Jeff Slezak, et autres
Publié: (2025)

Association of Benzodiazepine Prescription With Short‐Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT
par: Jesus Ruiz‐Ramos, et autres
Publié: (2024)

Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024
par: Luis Fernando Valladales‐Restrepo, et autres
Publié: (2026)

Neonatal Outcome Ascertainment in Mother‐Infant Paired Claims
par: Yehua Wang, et autres
Publié: (2026)